CardioArt Technologies
Noninvasive Measurement of Hemodynamic Parameters
Health Tech & Life Sciences
Non Active, Mar 2020 ceased to operate
Company Overview
Snapshot
Founded in February 2005 by Eyal Karev, CardioArt Technologies operated with 1–10 employees. The company secured a grant from the Office of the Chief Scientist, indicating early external validation for its technology.
Business overview
CardioArt Technologies developed technology for the noninvasive measurement of various hemodynamic parameters, aiming to reduce risks associated with invasive procedures like right heart catheterization. The company's initial product line focused on treating patients with congestive heart failure, operating within the Health Tech & Life Sciences sector, specifically in Medical Devices and Diagnostics Devices, targeting healthcare providers.
Company Intelligence Q&A
- What is CardioArt Technologies' primary focus?
- CardioArt Technologies focuses on developing technology for the noninvasive measurement of hemodynamic parameters, with an initial product line dedicated to treating patients with congestive heart failure.
- When was CardioArt Technologies founded?
- CardioArt Technologies was founded in February 2005.
- Who founded CardioArt Technologies?
- CardioArt Technologies was founded by Eyal Karev.
- What is the status of CardioArt Technologies?
- CardioArt Technologies is non-active and ceased to operate in March 2020.
- Did CardioArt Technologies receive any grants?
- CardioArt Technologies received a grant from the Office of the Chief Scientist.